Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

CPHI North America: Investors and Pharma Expect Manufacturers to Build ESG Into Operations

April 18, 2023

Bob Girton, partner at Edgewater, discusses best practices for how pharma manufactures should incorporate sustainability into their operations.

Stability in mRNA-LNP Formulations

April 15, 2023

Lipids aren’t the only important ingredients influencing stability and in vivo performance.

The Role of Separation Techniques in the Analysis of mRNA Therapeutic Drug Substances and Drug Products

April 15, 2023

This article reviews a range of techniques available for separative analysis of mRNA therapeutics, their associated impurities, and delivery vehicles.

The Marriage of RNA and Mass Spectrometry

April 15, 2023

Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

Examining Software as a Solution with Monil Malhotra (Emerson Automation Exchange)

April 14, 2023

Monil Malhotra, vice-president of Industrial Software at Emerson, discusses the growing demand for software solutions in the pharma industry.

Ginkgo Bioworks Acquires AAV Capsid Technology and Forms Partnership for Next-Gen CAR-T Cell Therapies

April 14, 2023

Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

April 14, 2023

The acquisition of Cell Systems will bolster AnaBios’ portfolio of human tissue and cells for use in drug discovery.

Discussing Manufacturing Operations with Michalle Adkins (Emerson Automation Exchange)

April 12, 2023

Michalle Adkins, director of Life Sciences Consulting at Emerson, discusses the structure of manufacturing organizations and how novel technologies may play a role in operations.

Addressing Data Security with Claudio Fayad (Emerson Automation Exchange)

April 07, 2023

Claudio Fayad, VP of Technology, Process Systems, and Solutions discusses the intersection of automation and data security in the pharma industry.

Marrying RNA and Mass Spectrometry

April 05, 2023

Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.